MESCIA, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.142
AS - Asia 1.470
EU - Europa 708
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 38
AF - Africa 31
OC - Oceania 3
Totale 4.662
Nazione #
US - Stati Uniti d'America 2.046
SG - Singapore 595
CN - Cina 283
HK - Hong Kong 247
BR - Brasile 220
IT - Italia 214
DE - Germania 108
VN - Vietnam 80
BD - Bangladesh 75
FI - Finlandia 72
GB - Regno Unito 67
CA - Canada 57
FR - Francia 55
TR - Turchia 52
RU - Federazione Russa 45
IN - India 40
IE - Irlanda 31
AR - Argentina 19
UA - Ucraina 19
JP - Giappone 18
NL - Olanda 18
MX - Messico 16
ID - Indonesia 14
IQ - Iraq 13
PL - Polonia 13
AT - Austria 12
ES - Italia 12
CO - Colombia 11
SA - Arabia Saudita 11
CR - Costa Rica 9
ZA - Sudafrica 9
LT - Lituania 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
SE - Svezia 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
EC - Ecuador 4
IL - Israele 4
JO - Giordania 4
LV - Lettonia 4
PH - Filippine 4
PR - Porto Rico 4
PS - Palestinian Territory 4
BE - Belgio 3
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
GY - Guiana 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
LU - Lussemburgo 2
LY - Libia 2
MY - Malesia 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
IR - Iran 1
KH - Cambogia 1
KI - Kiribati 1
MD - Moldavia 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.625
Città #
Singapore 293
Hong Kong 247
Ashburn 242
San Jose 226
Council Bluffs 138
The Dalles 74
Beijing 72
Los Angeles 67
Helsinki 56
Chandler 53
Columbus 45
New York 43
Lauterbourg 42
Istanbul 41
Dallas 40
Santa Clara 31
Dublin 29
Chicago 25
Buffalo 23
Phoenix 22
Atlanta 21
Frankfurt am Main 21
Moscow 21
São Paulo 21
Hanoi 20
Orem 20
Ho Chi Minh City 19
Munich 19
Denver 18
London 18
Nuremberg 18
Romola 18
Brescia 15
Montreal 15
San Francisco 15
Shanghai 15
Redondo Beach 14
Brooklyn 13
Jakarta 13
Milan 13
Tokyo 13
Chennai 12
Seattle 12
Rome 11
Wilmington 11
Amsterdam 10
Toronto 10
Turku 10
Bologna 9
Düsseldorf 9
Mexico City 9
Boston 8
Cambridge 8
Florence 8
Houston 8
Princeton 8
Rovito 8
Washington 8
Ankara 7
Memphis 7
Philadelphia 7
Woodbridge 7
Austin 6
Belo Horizonte 6
Bergamo 6
Charlotte 6
Dhaka 6
Fairfield 6
Kyiv 6
Lappeenranta 6
Las Vegas 6
Mumbai 6
Poplar 6
Porto Alegre 6
Tianjin 6
Warsaw 6
Brno 5
City of London 5
Elk Grove Village 5
Haiphong 5
Miami 5
Rio de Janeiro 5
San José 5
Stockholm 5
Vienna 5
Amman 4
Bengaluru 4
Des Moines 4
Detroit 4
Georgetown 4
Gonars 4
Guangzhou 4
Jacksonville 4
Jeddah 4
Johannesburg 4
Lowicz 4
Lübeck 4
Manaus 4
Manchester 4
Newark 4
Totale 2.545
Nome #
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 317
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 161
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity 149
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 142
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 141
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 110
Analysis of the B cell receptor repertoire in six immune-mediated diseases 109
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion 107
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 104
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 104
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination 101
Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients 99
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant 98
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 98
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 97
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis 94
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 94
Effective control of sars-cov-2 transmission between healthcare workers during a period of diminished community prevalence of covid-19 94
A thermostable, closed SARS-CoV-2 spike protein trimer 93
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 93
Eosinophilic granulomatosis with polyangiitis present and future 92
SARS-CoV-2 evolution during treatment of chronic infection 89
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 86
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease 86
Clinical Significance of the Cystic Phenotype in Alport Syndrome 85
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection 84
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 82
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 82
The impact of hypoxia on B cells in COVID-19 82
Treatment goals in ANCA-associated vasculitis: defining success in a new era 78
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups 76
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 74
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 73
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission 73
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report 71
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity 71
Prevention and Therapeutic Management of Bleeding in Dialysis Patients 69
Single-cell multi-omics analysis of the immune response in COVID-19 69
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies 67
STEC-HUS, atypical HUS and TTP are all diseases of complement activation 61
Kidney transplantation from a donor with acute kidney injury: An unexpected outcome 60
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 60
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience 56
Proinflammatory cytokines driving cardiotoxicity in COVID-19 55
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 53
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study 52
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity 48
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab 48
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID 44
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 37
#6036 CYSTIC KIDNEY PHENOTYPE IS A FREQUENT, AGE- AND EGFR- DEPENDENT FINDING IN ALPORT SYNDROME 29
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centres 22
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN 21
Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology 20
#1700 Clinical presentation and prognosis in ANCA-associated vasculitis with occupational exposure to silica: a monocentric retrospective study 18
#1722 Serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA associated vasculitis 17
FC061: Renal Function is a Major Determinant of B-Cell Repopulation Following Rituximab Induction in Anca-Associated Vasculitis 13
Kinetics of B Cell Repopulation After Rituximab in ANCA-Associated Vasculitis: Clinical Significance and Predictive Factors 13
#3579 AN INITIAL LOW-DOSE ETELCALCETIDE APPROACH IS EFFECTIVE AND COST-SAVING IN HEMODIALYSIS PATIENTS WITH MODERATE SECONDARY HYPERPARATHYROIDISM 11
The landscape of serum autoantibodies in lupus nephritis 11
Response to the Letter to the Editor entitled “Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings” 11
Primary Glomerular Diseases in the Elderly: Clinical Features, Treatment Patterns, and Outcomes in the CureGN Cohort 8
Totale 4.662
Categoria #
all - tutte 26.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 1 0 0 6 3 3 7
2022/2023174 7 0 5 18 5 59 0 21 37 2 10 10
2023/2024345 15 16 8 40 13 11 10 49 100 7 14 62
2024/2025942 4 10 28 109 73 90 83 87 102 97 170 89
2025/20262.167 198 260 166 204 180 175 330 88 143 216 138 69
2026/2027961 180 336 203 242 0 0 0 0 0 0 0 0
Totale 4.662